JAPAC Drug Development Strategies
Safety & Regulatory Considerations in Japan and China
Download the white paper “Understanding the Safety Strategies and Regulatory Considerations of Drug Development in the JAPAC Region” and learn about:
- Navigating the evolving local safety and regulatory guidelines for JAPAC.
- How the recent adoption of Good Pharmacovigilance Practices (GVP) has impacted China.
- Increasing efficiencies across JAPAC with Robotic Process Automation (RPA).
- Mastering the pharmaceutical nuances and reporting requirements in Japan.
- Taking advantage of IQVIA’s expertise in local case processing for Japanese language, Chinese database efficiency, and local safety and regulatory services across JAPAC.
LET’S TALK
Go beyond the download: request a consultation with a dedicated sales specialist.
